Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Digi-Prex
AddedFeb 15, 2024
UpdatedJul 3, 2026
Digi-Prex

Digi-Prex

Seed

Digi-Prex: An AI-powered platform for holistic chronic disease management, offering discounted medicines and home delivery.

HQ
San Francisco, CA, US
Founded
2019
Accelerator
Y Combinator logoY CombinatorS19
Overview
Compare
Fundraising
Employees
Website

Digi-Prex, founded with the mission to revolutionize chronic disease management, offers an AI-powered platform that provides a comprehensive solution for patients. The company focuses on delivering discounted medications directly to patients' homes at no additional cost, while also offering personalized lifestyle management solutions. By integrating AI, Digi-Prex ensures that patients with chronic diseases receive holistic care through a single platform, making chronic disease management more accessible and efficient.

Notable figures affiliated with Digi-Prex include key investors from prominent venture capital firms. The company has achieved significant milestones, such as reducing medication costs by up to a substantial percentage compared to local pharmacies and implementing a seamless prescription upload and reorder process. Digi-Prex's impact is evident in its ability to simplify medication management and improve the quality of life for patients with chronic diseases, positioning itself as a leader in the healthcare technology space.

Digi-Prex - Similar Companies

DiRx logo

DiRx

dirxhealth.com

NimbleRx logo

NimbleRx

nimblerx.com

Vitau logo

Vitau

vitau.mx

Medmonk logo

Medmonk

medmonk.com

Diasyst logo

Diasyst

diasyst.com

Jeevam Health logo

Jeevam Health

jeevamhealth.com

Medzoomer logo

Medzoomer

medzoomer.com

Health Haven Rx logo

Health Haven Rx

healthhavenrx.com

Gifthealth logo

Gifthealth

gifthealth.com

Sempre Health logo

Sempre Health

semprehealth.com

Remedial Health logo

Remedial Health

remedial.health

Redi.Health logo

Redi.Health

redi.health

Pills2Me logo

Pills2Me

pills2me.com

ScriptAssist Pharmacy logo

ScriptAssist Pharmacy

scriptassistrx.com

RxDiet logo

RxDiet

rx-diet.com

Digi-Prex - Quick Facts

Who are Digi-Prex's competitors?

Companies similar to Digi-Prex include DiRx, NimbleRx, Vitau and Medmonk.

When was Digi-Prex founded?

Digi-Prex was founded in 2019.

Where is Digi-Prex's headquarters located?

Digi-Prex's headquarters is located in San Francisco, CA, US.

When was Digi-Prex's last funding round?

Digi-Prex's most recent funding round was for $5.5M (USD) in September 2019.

How much has Digi-Prex raised to-date?

As of Sep 20, 2019, Digi-Prex has raised a total of $5.5M (USD).

How many employees does Digi-Prex have?

Digi-Prex has 200 employees as of Feb 4, 2024.

Digi-Prex - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medication Delivery
Tags
  • Healthtech
NAICS
  • 524000Insurance Carriers and Related Activities
  • 524100Insurance Carriers
  • 524110Direct Life, Health, and Medical Insurance Carriers
  • 524114Direct Health and Medical Insurance Carriers
  • 520000Finance and Insurance
SIC
  • 6300Insurance Carriers
  • 6320Accident And Health Insurance And Medical Service Plans
  • 6321Accident And Health Insurance
Show 9 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 620000Health Care and Social Assistance
SIC
  • 8060Hospitals
  • 6000Depository Institutions
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified